Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 19,993-20,004 of 23,847
Drug study icon
CompletedNCT00000284

Role of Metabolites in Addiction (1) - 1

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
AddictionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Addiction
Drug study icon
CompletedNCT00000288

Role of Metabolites in Addiction (2) - 5

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
AddictionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Addiction
Drug study icon
CompletedNCT00000289

Role of Metabolites in Addiction (3) - 6

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
AddictionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Addiction
Drug study icon
CompletedNCT00000296

Role of Metabolites in Addiction (4) - 13

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
AddictionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Addiction
Drug study icon
CompletedNCT00916461

Role of Minocycline in First Episode Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including São Paulo
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Brazil, Pakistan
Sponsor
Stanley Medical Research Institute
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT05910775

Role Of Non-Specific Effects in The Treatment of Depression With Esketamine

This study exists to understand how ketamine treatment holds up over time after the earliest research stage. Researchers are trying to understand what ketamine treatment could change in day-to-day care and decision-making.

In New Haven
DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Yale University
Condition
Depression
Drug study icon
TerminatedNCT01631630

Role of Proinflammatory Signaling in Alcohol Craving

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.